Celltrion Inc. produces and sells biosimilar products and also provides consignm ent processing service for other companies.  The Company's main product is Abata cept which is for arthritis treatment

Decision on Paid-in Capital Increase (Material Business Matters of Subsidiary Company)

[Revised] Decision on Acquisition of Shares or Investment Certificates of Other Corporations (Voluntary Disclosure)(Material Business Matters of Subsidiary Company)

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Celltrion Inc (068270 KS)

Decision on Paid-in Capital Increase (Material Business Matters of Subsidiary Company)

[Revised] Decision on Acquisition of Shares or Investment Certificates of Other Corporations (Voluntary Disclosure)(Material Business Matters of Subsidiary Company)

Decision on Acquisition of Shares or Investment Certificates of Other Corporations

Decision on Closure of Shareholderâs Registry(Including Record Date) for Dividends

Decision on Cash Dividends and Dividends in Kind

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)

Decision on Paid-in Capital Increase (Material Business Matters of Subsidiary Company)

[Revised] Decision on Acquisition of Shares or Investment Certificates of Other Corporations (Voluntary Disclosure)(Material Business Matters of Subsidiary Company)

Decision on Acquisition of Shares or Investment Certificates of Other Corporations

Decision on Closure of Shareholderâs Registry(Including Record Date) for Dividends

Decision on Cash Dividends and Dividends in Kind

Decision on Closure of Shareholderâs Registry(Including Record Date) for Dividends